The number of critical medication shortages in the United States has reached an unprecedented level, requiring decisions about allocating limited drug supplies.
Anemia in patients undergoing CABG with CPB is bad, but blood transfusion can be worse, increasing at least 50% the risk for mortality and/or morbidity.
